Our group aims to apply computational neuroscience to clinical neurology.
We try to break cognition down into its elementary computational steps, asking what quantities the healthy brain must be using.
Then we try to understand how these steps map on to brain areas and chemicals, e.g. using brain imaging (fMRI, EEG and MEG)
Finally, we ask whether medications can modify cognition. We are particularly interested in the motivational effects of dopamine and acetylcholine.
Next we study how neurological diseases, such as stroke or dementia, can disrupt cognition. This needs detailed, quantitative characterisation of the clinical problem by studying how patients perform carefully designed tasks.
Publications on Google Scholar (sorted by impact)
Pubmed (sorted by year)
[publications name=homphysiology]